Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 9.85B | 8.29B | 8.02B | 7.86B | 8.47B |
Gross Profit | 1.23B | 1.22B | 928.60M | 1.03B | 1.22B |
EBITDA | 808.18M | 743.52M | 131.36M | 308.89M | 187.29M |
Net Income | 241.95M | 247.57M | -540.13M | -121.40M | -82.33M |
Balance Sheet | |||||
Total Assets | 16.14B | 15.36B | 14.99B | 14.99B | 15.30B |
Cash, Cash Equivalents and Short-Term Investments | 2.67B | 2.71B | 4.41B | 4.34B | 4.84B |
Total Debt | 1.26B | 1.22B | 1.26B | 1.24B | 1.28B |
Total Liabilities | 4.91B | 4.62B | 4.71B | 4.13B | 4.36B |
Stockholders Equity | 11.23B | 10.73B | 10.28B | 10.86B | 10.94B |
Cash Flow | |||||
Free Cash Flow | -143.64M | -1.44B | -311.55M | -410.82M | 583.28M |
Operating Cash Flow | 866.32M | -515.64M | 241.20M | 58.36M | 950.06M |
Investing Cash Flow | -877.36M | -895.23M | -137.04M | -496.27M | -101.58M |
Financing Cash Flow | -30.99M | -288.90M | -33.92M | -60.45M | -92.69M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥4.20B | 4.68 | 7.62% | -28.71% | -31.89% | ||
74 Outperform | ¥4.00B | 16.63 | 1.86% | 14.03% | -34.37% | ||
73 Outperform | ¥3.59B | 7.27 | 1.65% | -4.62% | 21.46% | ||
68 Neutral | ¥3.45B | 13.70 | 1.32% | 30.06% | -11.98% | ||
60 Neutral | ¥4.38B | 13.12 | 2.61% | -1.27% | 72.61% | ||
59 Neutral | ¥3.29B | 58.34 | 1.65% | 2.91% | -154.96% | ||
58 Neutral | HK$14.00B | 5.72 | -2.78% | 5.72% | 2.33% | -57.85% |